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Trihydroxycinnamic derivatives were synthesized and evaluated for their antioxidant and cyto-
toxic activities. The ester derivatives exhibited a higher radical-scavenging activity, when lipo-
somes were used as target systems, a fact which may be related to their lipophilicity and confor-
mational preferences. These compounds were found to display significant growth inhibition
and cytotoxic effects towards a human cervix adenocarcinoma cell line (HeLa). The partition
coefficients presently obtained for the trihydroxycinnamic derivatives correlate well both with
their structural characteristics and with their antioxidant/cytotoxic activities. A positive struc-
ture-activity-property relationship between cytotoxic and antioxidant activities, which is
intrinsically related with physico-chemical and conformational properties, is anticipated, as a
noteworthy study that must be done for phenolic systems. As damage events are frequently cor-
related with oxidative stress, the prevalence of both properties in a single compound could be
beneficial in terms of rationale preventive or therapeutic purposes.
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Introduction
Polyphenols, bioactive substances commonly found in
plants, are reducing agents supposed to be involved in
the defense against oxidative damage due to their antiox-
idant and radical-scavenging characteristics [1–5].
Among polyphenolic compounds, hydroxycinnamic
acids (e. g. ferulic and caffeic acids) are a well-known
group of natural compounds, which are present in the
human diet in representative amounts. Apart from being
widely used as food additives [6, 7], some phenolic deriv-
atives have been found to act as inhibitors of deleterious
oxidative processes – e. g. in the prevention of cardiovas-
cular and inflammatory diseases and cancer [8–15]. In
fact, several phenolic compounds have been investigated
as to their possible use as chemopreventive agents [16–
18]. Cinnamic acid esters, in particular, were shown to
display remarkable growth-inhibition properties
towards some human cancer cell lines [17–20]. Neverthe-
less, the mechanisms underlying the protective action of
phenolic compounds towards degenerative pathologies
are not yet completely understood, although numerous
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evidence indicates that they are intrinsically linked to
their antioxidant activity and strongly dependent on
their structural characteristics [21–24]. Moreover, the
biological activity of this type of compounds is thought
to be determined by their rate of incorporation into the
cell, which is directly related to their lipophilicity (also
greatly influenced by their chemical and conformational
preferences). In the last few years, this subject has
become an emergent topic of research [25, 26], both in
the field of medicinal and food sciences, in view of devel-
oping new and more effective phenolic agents suitable
for both chemopreventive and therapeutic purposes (e. g.
against neoplastic pathologies), or to be used as antioxi-
dant additives (in food products).
Accordingly, an interactive project is being developed
aiming at attaining a more reliable understanding of the
structure-property-activity relationships (SPAR) underly-
ing the biological function, particularly antioxidant and
anticancer, of several phenolic systems, either of natural
or synthetic origin, in order to acquire a better insight
into their mechanisms of action. On the other hand, the
co-administration of two compounds acting by different
mechanisms may have a synergistic effect, resulting in a
higher activitywithout raising thedose required toobtain
the same effect with a single compound [27, 28]. Likewise,
an agent that possesses more than one mechanism of
action may have a net therapeutic effect greater than the
sumof the effects due to the individual components.
In the present study, the antioxidant properties of the
hydroxycinnamic acid derivative trans-3-(3,4,5-trihydrox-
yphenyl)-2-propenoic acid 1 and its esters trans-ethyl-3-
(3,4,5-trihydroxyphenyl)-2-propenoate 2 and diethyl 2-
(3,4,5-trihydroxyphenylmethylene)malonate 3 (Fig. 1)
were evaluated, using total antioxidant capacity (TAC)
and lipoperoxidation assays. Their cytotoxic activities
were determined, in both cancer (cervix adenocarci-
noma, HeLa) and non-neoplastic (skin fibroblasts, BJ)
human cell lines. The partition coefficients (log P) of
these compounds were also measured, in a liposome/buf-
fer system. Furthermore, theoretical methods (ab-initio
molecular orbital calculations) were used for the deter-
mination of the conformational preferences of the com-
pounds under study [29], which are essential for a thor-
ough interpretation of the biological results presently
obtained, as well as for attaining reliable structure-activ-
ity or structure-property-activity relationships for this
type of systems.
Results and discussion
Conformational analysis
The most stable geometries, relative energies, and popu-
lations at room temperature for the phenolic acid and
ester derivatives under study were obtained by ab-initio
molecular orbital calculations, at the DFT (density func-
tional theory) level. Several structural parameters were
varied, in order to determine their effect on the overall
stability of these systems: i) orientation of the ethyl sub-
stituent relative to the aromatic ring; ii) orientation of
the ring and the carbonyl group relative to the carbon-
chain C=C bond, defining trans or cis isomers; iii) orienta-
tion of the ethyl moiety relative to the carbonyl, defining
s-cis or s-trans conformations; iv) localization of the phe-
nolic groups relative to the plane of the ring (either in-
plane or out-of-plane).
For the three compounds investigated, a planar or
quasi-planar geometry was found to be favored, due to
the stabilizing effect of the p-electron delocalization
between the coplanar aromatic ring and carbon chain
C=C bond (Fig. 1). Regarding the orientation of the ring
hydroxyl groups, it was verified that an identical position
of the three OH's, coplanar with the ring, yield the most
stable structures, since it allows a minimization of the
steric repulsions between adjacent OH's and the forma-
tion of medium strength intramolecular O … H bonds
(dO…H ca. 218 pm). The data obtained are in accordance
with that previously acquired for similar phenolic sys-
tems [30, 31].
This type of information is widely recognized to be
important for a better understanding of the antioxidant
activity, on a molecular basis, of phenolic compounds as
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Figure 1. Schematic representation of the most stable geome-
tries calculated for the phenolic compounds under study (at the
B3LYP/6-31G** level): trans-3-(3,4,5-trihydroxyphenyl)-2-prope-
noic acid 1, trans-ethyl-3-(3,4,5-trihydroxy-phenyl)-2-propenoate
2, and diethyl 2-(3,4,5-trihydroxyphenylmethylene)malonate 3.
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electron or H-donating agents, since it can be related to
the stabilization of the phenoxyl radical intermediates
formed in situ [32]. Moreover, the knowledge of the true
spatial arrangement of this kind of compounds is rele-
vant for interpreting the biological data, mainly the
interaction of these molecules with particular receptors
and/or other types of targets (e. g. lipids, DNA, carbohy-
drates, or proteins).
Antioxidant activity
Total antioxidant capacity assays
Total antioxidant capacity (TAC) assays were used in
order to determine the hierarchy of radical scavenging
abilities of the phenolic acid and its ester derivatives, by
measuring their ability to scavenge 2,29-azinobis(3-ethyl-
benzothiazoline-6-sulphonic (ABTS+9) or 2,29-diphenyl-1-
picrylhydrazyl (DPPH9) radicals. These methods have the
advantage of establishing an accurate ranking hierarchy
of antioxidant activity of electron- or H-donating agents,
since they are not affected by some factors which inter-
fere in other model systems, such as metal chelation or
partitioning abilities [21–23].
In addition, the effect of the phenolic compounds on
the inhibition of lipid peroxidation in liposomes was
also evaluated, using different and complementary
methodologies. Trolox was introduced in all assays as a
reference antioxidant, in order to get reliable data as tro-
lox equivalent antioxidant capacity (TEAC) values.
Figures 2 and 3 display the results obtained in the TAC
assays using ABTS+9 [33, 34] and DPPH9 [33, 35] radicals,
after 20 and 60 min of reaction, respectively. The results
depicted in Fig. 2 evidence noticeable antioxidant behav-
iors for the compounds under study, when compared to
trolox. According to previous statements, this may be
explained by the presence of hydroxyl groups in their
structures, which are intrinsically related with their anti-
radical properties [17, 18, 21]. It is noteworthy that an
equilibrium was almost reached after 5 min (Fig. 4), ren-
dering those compounds as fast as trolox as ABTS+9 scav-
engers. The DPPH assay yielded a similar antiradical ten-
dency for the phenolic compounds studied (Fig. 3),
although the difference in antioxidant activity between
them was not so evident. The distinct chemical structure
and reactivity of the radicals used in the two experimen-
tal evaluationsmight explain these discrepancies.
Lipoperoxidation assays
As lipid peroxidation is likely to be involved in the devel-
opment of certain diseases such as cancer, atherosclero-
sis, and neuron impairment, evaluation of the antioxi-
dant behavior of the compounds towards this specific tar-
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Figure 2. Dose/response curves for the scavenging of ABTS+9
by the phenolic compounds under study, after 20 min of reac-
tion.
Figure 3. Dose/response curves for the scavenging of DPPH9
by the phenolic compounds under study, after 60 min of reac-
tion.
A: ABTS, after 5 min.; B: ABTS, after 20 min.; C: DPPH; D: lipoperoxidation, with
DPH-PA as probe; E: peroxidation, with fluorescein as probe; F: lipoperoxidation, with
fluorescein as probe.
Figure 4. TEAC values for the phenolic compounds under
study, from TAC and peroxidation assays.
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get was carried out [36]. EPC (egg phosphatidylcholine)
unilamellar liposomes were used as biomimetic mem-
brane models [37], due to their similar structural charac-
teristics. The advantage of using this type of systems,
such as unilamellar versusmultilamellar liposomes and a
water-soluble radical azo-generator (2,29-azobis(2-amidi-
nopropane) dihydrochloride; AAPH), is largely docu-
mented in the literature [38]. In AAPH-induced peroxida-
tion of unilamellar liposomes, the chain-initiating radi-
cal is generated in the aqueous phase and the chain-prop-
agating lipid peroxyl radicals are located within the
membranes.
One well-liked model for evaluation of the antioxidant
efficiency towards the inhibition of lipid peroxidation is
the oxygen radical absorbance capacity (ORAC) method.
This assay was originally performed bymeasuring the flu-
orescence decay of b-phycoerythrin (b-PE) after AAPH oxi-
dation [39]. However, Ou and co-workers [40] developed
an improved ORAC assay in which b-PE is replaced by flu-
orescein, since the former has some drawbacks due to its
photo(in)stability and the possibility of its interaction
with the compounds under analysis. The method was
also adapted to be employed with liposome systems and
applied for 96-well microplate fluorescence readers [41–
43], enabling the analysis of a broader range of com-
pounds such as lipophilic antioxidants. In turn, as fluo-
rescein, due to its hydrophilic properties, only allows
evaluating the radical-scavenging activity of compounds
in an aqueous phase, a different method was exploited
using a lipophilic fluorescent probe, DPH-PA (diphenyl-
hexatriene propionic acid), and the same peroxyl radical
initiator [44].
In summary, protection against lipoperoxidation was
presently evaluated using AAPH as a peroxyl radical azo-
initiator [44] and two radical-sensitive fluorescent
probes, one hydrophilic and one lipophilic (fluorescein
and DPH-PA, respectively). The scavenging activity
towards peroxyl radical was also assessed in a buffer solu-
tion, with the same azo-initiator and fluorescein. The
results obtained in these three assays were expressed as
TEAC values (Fig. 4).
The data gathered from these lipoperoxidation assays
evidence that the ester derivatives 2 and 3 display an
enhanced antioxidant activity when compared to their
parent acid 1 (Fig. 4). Esterification of 1 seems to increase
the activity of the acid when heterogeneous lipidic sys-
tems (liposomes) were used. Thus, it was believed that the
capacity to scavenge peroxyl radicals can be intrinsically
related to the lipophilicity difference between the com-
pounds tested, a premise that was validated by the parti-
tion coefficient values of the compounds (see below; Sec-
tion 2.3).
The protective effects of the phenolics under study on
biomimetic membranes were mainly associated to the
hydrophilicity/hydrophobicity of the compounds, since
they possess the same number of hydroxyl groups and an
identical aromatic pattern. The scavenging-activity
results obtained in a buffer medium and in liposomes
allow to conclude that this type of compounds act at the
membrane surface. In addition, the antioxidant action of
3 may be related to the change in membrane fluidity,
thus affecting the lipid ordering at a different depth in
the bilayer (data not shown), as its activity is higher in
the DPH-PA assay. Furthermore, the chemical structure
of the phenolic compounds investigated has an intrinsic
relationship with the membranes: their polar groups
interact at the lipid-water interface with the polar head
groups of the membrane phospholipids. This fact plays
an important role on phenolic distribution in biological
systems and consequently determines its local concentra-
tion, which then influences their capacity to regulate cel-
lular events. Also, this kind of orientation on the mem-
brane surface can affect the access of oxidants to the
bilayer and/or control the rate of propagation of the free
radical chain reactions occurring at the hydrophobic
core of membranes, thus contributing to preserve the
structure and function of biological membranes [45]. The
results presently reported support the hypothesis that,
besides the number of hydroxyl groups and the intramo-
lecular hydrogen-bond formation, the exhibited activity
is intrinsically related with the polar head group of lipids
and the spatial arrangement of the compounds (see con-
formational analysis data).
Partition coefficients
The partition coefficient values (log P) were determined
for the compounds studied in a liposome/buffer system
(pH = 7.4), according to themethod of Kitamura et al. [46],
in order to correlate the results obtained in the heteroge-
neous systems (liposomes and cells) to the lipophilicity of
the phenols. The log P values for 2 and 3 were 3.48 l 0.02
and 3.12 l 0,10, respectively (Figs 5A and 5B). As the phe-
nolic acid 1 did not show any partition in these experi-
mental conditions, its log P was determined by derivative
spectrophotometry using micelles of 1-hexadecylphos-
phoryl-choline (HDPC) (2.18 l 0,63 [47]). The phenolic acid
is ionized at physiological pH and its antioxidant effect is
believed to takeplace in theaqueousphase [47]. Theability
of the phenolic ester 2 to interact with the membrane
polar head groups, increasing their local concentration at
thewater-lipid interface ofmembranes,maybe one factor
leading to ahigher antioxidant capacity.
Prevention of the initial reaction between aqueous rad-
icals and membrane phospholipids is very important
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since it plays an essential role in the antioxidant defense
of biomembranes, which suffer a continuous attack by
free radicals generated in the aqueous phase of cellular
and subcellular fractions.
Antiproliferative and cytotoxic activity
The antineoplastic properties of the phenolic compounds
investigated were evaluated in a human cervix adenocar-
cinoma cell line – HeLa (epithelial-like adherent line). In
order to determine their degree of toxicity towards
healthy cells, experiments were also performed in fibro-
blasts from human skin (BJ). All the results reported were
gatheredby two independentmethods,whichwere found
to be in very good agreement: cell density measurement
(Trypan blue exclusion method) and cell viability evalua-
tion (Alamar colorimetric assay). In all experiments, cis-
platin (cis-diaminedichloroplatinum(II), CDDP), 4 was
used for comparison purposes, since it is one of the most
widelyused chemotherapeutic drugs in clinical practice.
Figure 6 represents the cytotoxic effect of the phenolic
compounds tested against the HeLa and BJ cell lines –
cell viability variation as a function of the incubation
time with the drug, for different drug concentrations
(between 25 and 100 lM). From these time- and dose-
response plots, it is possible to relate the structural char-
acteristics of the compounds to their antiproliferative
activity, thus learning on factors such as specificity of
action and reversibility of the drug effect. The linear ester
2 showed to have the highest growth-inhibition and cyto-
toxic effects towards the HeLa cell line, followed by its
acid 1 and diester 3 counterparts. This antineoplastic
activity was determined as being of significance only
after 72 hours of incubation with the drug, and it did not
change much upon removal of the phenolic agents, thus
evidencing a strong irreversibility of their effect (Fig. 6).
In fibroblasts, in turn, none of the compounds tested dis-
played a significant toxicity (even after eight days of incu-
bation). Moreover, upon removal of the compounds, the
cell viability was found to reach ca. 100% (after 4 days in
the absence of drug, Fig. 6) for all three phenols. As to the
effect of drug concentration, the results clearly evidence
that values above 50 lM should be used in order to get a
significant growth-inhibition effect (up to ca. 50% viabil-
ity decrease, for themonoester 2, Fig. 6).
Overall, considering the effect on both HeLa cancer
cells and fibroblasts, the ethyl ester 2 proved to be the
most efficient cytotoxic agent as compared to the parent
acid and diester analogue. This is suggested to be due to
the more efficient transport mechanism of the linear
ester into the cell, as compared to the charged molecule
of the acid 1 and the bulkier branched diester molecule
3. The results presently obtained for these hydroxycin-
namic acid derivatives are in accordance with those pre-
viously reported for both caffeic and gallic esters [17, 18].
Conclusions
The results gathered from the studies developed in this
area allow concluding that the antitumor activity of phe-
nolic derivatives is highly dependent upon their confor-
mational characteristics, which, in turn, determine their
antioxidant properties. Moreover, researchers are plac-
ing increasing emphasis on identifying the biological
mechanisms underlying the antiproliferative/cytotoxic
activity of phenols [24]. In particular, it was shown that
they can exert an effect on signal-transduction pathways,
separately or sequentially, and that possible crosstalk
between these pathways cannot be overlooked. Potential
mechanisms of this type of compounds can be related
with their protection against oxidative damage, either
through their cytotoxic effect against malignant cells or
via a pure scavenging-radical activity [24].
The present study on trans-3-(3,4,5-trihydroxyphenyl)-
2-propenoic acid 1 and its esters trans-ethyl-3-(3,4,5-trihy-
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Figure 5A and 5B. Best fit of the second derivative at 350 nm,
for the phenolic esters 2 (A) and 3 (B), for different concentra-
tions of EPC.
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droxyphenyl)-2-propenoate 2 and diethyl 2-(3,4,5-trihy-
droxyphenylmethylene)malonate 3 allowed to verify
that the esterification of hydroxycinnamic precursors
significantly improves their antioxidant capacity against
lipoperoxidation, as well as their cytotoxic activity. The
antioxidant activity towards peroxyl radicals exhibited
by the esters may explain their capability to reduce carci-
nogenesis through cell protection against oxidative dam-
age. In fact, the linear ester 2 was found to be the most
efficient cytotoxic agent towards human adenocarci-
noma, as compared to its parent acid and diester ana-
logues. It is noteworthy that none of the compounds eval-
uated displayed a significant toxic effect against healthy
cells. These results agree well with the lipophilic proper-
ties of the polyphenols, which are known to be closely
related to their bioavailability at the biological target,
thus ruling their cytotoxic activity.
The theoretical calculations carried out for these
hydroxycinnamic compounds yielded their most stable
structures, which are responsible for the biological activ-
ities presently evaluated. This information is essential for
an accurate interpretation of these experimental results
– lipophilicity, antioxidant, and growth-inhibition prop-
erties – as well as for achieving reliable structure-prop-
erty-activity relationships (SPAR's), capable of explaining
the biological role of this kind of systems.
Although the antioxidant and/or the anticancer activ-
ity of phenolic acids and derivatives has been evaluated
in different model systems, few studies have been per-
formed to this date in order to get an insight into the
SPAR's underlying these functions. Moreover, physico-
chemical data obtained for these systems is important to
enlighten some currently accepted models (and mecha-
nisms) at themolecular level. In fact, the results gathered
along this and other works [7, 17, 18, 21] have shown
beyond doubt that the antioxidant and anticancer activ-
ities of the hydroxycinnamic derivatives are intrinsically
dependent on their structural characteristics, namely
the number of hydroxyl groups, and the presence of alkyl
ester side chains and their chemical nature (e. g. linear vs
branched, saturated vs unsaturated). Therefore if evident
SPAR were found to rule the antioxidant/antiprolifera-
tive activities of these compounds, this being an effective
approach for the design of new therapeutic agents as
well as for the understanding of their mechanisms of
action. Further research is presently in progress in order
to find lead compounds displaying both antioxidant and
growth-inhibition properties, thus being promising
agents for cancer therapy.
Christophe Siquet wishes to thank FCT (SFRH/BD/7005/2001)
for financial support.
Experimental
Reagents
2,29-Azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), egg
L-a-phosphatidylcholine (EPC), 2,29-diphenyl-1-picrylhydrazyl
(DPPH), fluorescein sodium salt, 2-carboxy-2,5,7,8-tetramethyl-6-
chromanol (trolox), 2,29-azobis(2-amidinopropane) dihydro-
chloride (AAPH) were obtained from Sigma-Aldrich-Fluka (Sin-
tra, Portugal). Diphenylhexatriene propionic acid (DPH-PA) was
obtained from Molecular Probes (Leiden, The Netherlands). All
other reagents and solvents were pro-analysis grade, purchased
from Merck (Lisbon, Portugal). Antibiotics (penicillin-streptomy-
cin 1006solution), cisplatin (cis-diaminedichloro-platinum(II)),
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Cells (56105 cells/mL) were incubated with the drugs for periods of 24 to 72 h. Every 24 h, aliquots of the cell suspensions were removed and cell viability was evaluated by the
Alamar blue colorimetric assay (as described in the Experimental, Section). In addition, the drug was removed 72 h after seeding and the cell viability was assessed following a
further incubation of 96 h. The data are expressed as a percentage of the control Alamar reduction (100%) and represent the average l mean standard deviation from two inde-
pendent experiments carried out in triplicate. * Intergroup comparison: p a 0.05. (Values for cisplatin (CDDP, 4) are included for comparison).
Figure 6. Time-dependence of the cytotoxic effect of phenolic compounds 1, 2, 3 against HeLa (A) and BJ (B) cell lines.
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DMEM-HG culture medium, EDTA (ethylenediaminetetraacetic
acid, disodium salt, dihydrate), glutamine, HEPES (N-[2-hydroxy-
ethyl]piperazine-N9-[4-butane-sulphonic acid]), phenol red (phe-
nol-sulfonphthalein), Trypan blue (0.4% solution, prepared in
0.81% sodium chloride and 0.06% dibasic potassium phosphate),
trypsin, trisodium citrate, inorganic salts and acids (of analytical
grade) were purchased from Sigma-Aldrich Chemical Co.
(Madrid, Spain). Fetal calf serum was obtained from Biochrom
KG, Berlin. Alamar blue was acquired from Accurate Chemical &
Scientific Corporation, Westbury, NY, USA.
The HeLa and BJ cell lines were purchased from the European
Collection of Cell Cultures (ECACC, United Kingdom).
Apparatus
Infrared spectra were recorded on an ATI Mattson Genesis Series
FTIR spectrophotometer (Mattson Instruments, Inc., Madison,
WI, USA) using potassium bromide disks. Only the most signifi-
cant absorption bands are reported (mmax, cm– 1). 1H- and 13C-NMR
data were acquired, at room temperature, on a Bruker AMX 300
spectrometer (Bruker Bioscience, Billerica, MA, USA) operating
at 300.13 and 75.47 MHz, respectively. Dimethylsulfoxide-d6 was
used as a solvent; chemical shifts are expressed in d (ppm) values
relative to tetramethylsilane (TMS) as an internal reference; cou-
pling constants (J) are given in Hz. Assignments were also made
from DEPT (distortionless enhancement by polarization trans-
fer) (see underlined values). Electron impact mass spectra (EI-MS)
were carried out on a VG AutoSpec instrument (Fisons Instru-
ments, Mainz, Germany); the data are reported as m/z (% of rela-
tive intensity of the most important fragments). Melting points
were obtained on a Kfler microscope (Reichert Thermovar,
Vienna, Austria) and are uncorrected. UV/Vis and fluorescence
measurements, for TAC, lipoperoxidation, and partition coeffi-
cient determination assays, were performed on a Bio-Tek Syn-
ergy HTmultiplate reader (Biotek, Winooski,. VT, USA).
Synthesis
Trans-3-(3,4,5-trihydroxyphenyl)-2-propenoic acid 1,
Trans-ethyl-3-(3,4,5-tri-hydroxyphenyl)-2-propenoate 2,
and Diethyl 2-(3,4,5-trihydroxyphenyl-
methylene)malonate 3
The phenolic compounds studied in the present work were syn-
thesized according to an adaptation of the process described by
Hbner et al. [48]. The reaction is of Knoevenagel type, occurring
between the corresponding trihydroxybenzaldehyde (1 g) and
malonic acid (1.2 g) or monoethylmalonate or diethylmalonate
in pyridine (5 mL) using aniline (four drops) as catalyst. All reac-
tions took place at 508C for 20 h, and were followed by thin layer
chromatography (TLC). The solvents were partially evaporated
after the synthetic reaction; the productwas dilutedwith diethyl
ether andwashed twicewith2N HCl andwater. Theorganic layer
was then dried over anhydrous magnesium sulphate, filtered,
and concentrated. The remaining residueswere crystallized from
dichloromethane/n-hexaneor frommethanol/water.
The newly synthesized compounds were identified by both
NMR and EI-MS. The data obtained for 1 and 2 is in accordance
with that described in Fiuza et al. [30].
Diethyl 2-(3,4,5-trihydroxyphenylmethylene)malonate 3
Yield 70%; IR: 3388, 3282, 1720, 1672, 1600, 1535, 1465,
1375,1326, 1272, 1234, 1149, 1078, 1032, 939, 837, 766, 731,
665, 631. 1H-NMR d: 1.23 (6H, t, COOCH2CH3), 4.19 (2H, q,
COOCH2CH3), 4.30 (2H, q, COOCH2CH3), 6.48 (2H, s, H(2), H(6)),
7.37 (1H, s, H(b)), 9.20 (3H, s, OH); 13C-NMR d: 13.8 (OCH2CH3), 14.1
(OCH2CH3), 61.1 (OCH2CH3), 61.3 (OCH2CH3), 109.4 (CH(2, 6)), 121.7
(C(1)), 122.3(C(a)), 137.2 (C-OH), 142.0 (CH(b)), 146.0 (C-OH), 164.0
(C=O), 166.6 (C=O); EI-MS m/z (%): 296 [M+9] (100), 251 (36), 222
(38), 205 (49), 178 (38), 150 (58), mp. 182–1848C (1568C subl.).
Ab-initiomolecular orbital calculations
The most stable conformations of the three phenolic com-
pounds presently studied were obtained by ab-initio molecular
orbital (MO) calculations. Full geometry optimization was per-
formed using the GAUSSIAN 98W program [49], within the Den-
sity Functional Theory (DFT) approach in order to properly
account for the electron correlation effects (particularly impor-
tant in this kind of systems). The widely employed hybrid
method denoted by B3LYP [50–55], which includes a mixture of
HF and DFT exchange terms and the gradient-corrected correla-
tion functional of Lee, Yang, and Parr [56, 57], as proposed and
parameterized by Becke [58, 59], was used, along with the dou-
ble-zeta split valence basis set 6-31G** [60, 61]. Molecular geome-
tries were fully optimized by the Berny algorithm, using redun-
dant internal coordinates [62]: the bond lengths to within ca.
0.1 pm and the bond angles to within ca. 0.10. The final root-
mean-square (rms) gradients were always less than 3610– 4 har-
tree.bohr – 1 or hartree.radian – 1. No geometrical constraints
were imposed on themolecules under study.
Total antioxidant capacity assays
Total antioxidant capacity (TAC) assays were carried out using
ABTS and DPPH as radicals. The experimental procedures were
adapted from the literature, with slight modifications in order
to be applied to amultiplate reader [63–67].
Before themeasurements, the concentration of the ABTS9+ and
DPPH9 solutions was adjusted with ethanol to yield an absorb-
ance of 0.45 l 0.01 at 734 nm (at 308C) and of 0.38 l 0.01 at
515 nm (at 258C), respectively, for 180 lL of solution in the plate
reader.
Six solutions of each compound were prepared in ethanol,
with concentrations between 1.5610 – 5 and 1.5610 – 4M. The
absorbances of 20 lL of each solution and 180 lL of radical (in
quadruplicate) were recorded every 5 min, during 20 min, for
ABTS9+ and every minute, during 10 min, then every 5 min, dur-
ing the next 50 min, for DPPH9. The absorbance of a blank con-
trol (20 lL ethanol + 180 lL of radical) was set as 100% of radical
(0% bleaching). Trolox was used as a reference antioxidant.
The concentrations of the radicals (ABTS9+ and DPPH9) were
plotted as a function of the phenolic concentration: after 5 and
20 minutes of reaction time for ABTS9+, and after 60 min of reac-
tion time for DPPH9. Second degree polynomial regressions of
the experimental points were generated, with a y-axis intercept
at 100% of radical. TEAC value was the ratio between the trolox
concentration needed to bleach 50% of the radical (IC50) and the
phenolic concentration needed to achieve the same effect, for
each of the reaction times considered. The trolox equivalent
antioxidant capacity (TEAC) value was the average of the TEAC
values obtained from two independent determinations.
Lipoperoxidation assays
Liposomes preparation – EPC (15.75 mg, 2.25610 – 5mol) was
dissolved in a 50 mL round flask containing 10 mL of a CHCl3/
CH3OH (3 : 1) mixture. The solvent was evaporated on a rotava-
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por at 308C, under a nitrogen flow in a light-protected environ-
ment, leaving a homogeneous lipidic film on the flask wall. The
film was kept in a dessicator, under vacuum and protected from
light, until further use. Before the measurements, this film was
vigorously shaken for 20 min in a vortex mixer with 15 mL of a
Hepes solution (5 mM)/NaCl (0.1 M), in order to obtain a suspen-
sion of MultiLamellar Vesicles (MLVs). This suspension was
extruded ten times through a 100 nm pore polycarbonate filter
(Nucleopore, Whatman), yielding a suspension of large unila-
mellar vesicles (LUVs).
Fluorescein assay
The antioxidant capacity of the compounds investigated was
evaluated by an oxygen radical absorbance capacity (ORAC)
assay, using fluorescein as the fluorescent probe and AAPH as
the radical initiator. The determination was performed either in
a buffer or in a liposome (LUVs)/buffer media. All solutions were
prepared in a potassium phosphate buffer (75 mM, pH 7.4, ionic
strength adjusted to 0.1 Mwith NaCl).
The final concentrations of the reagents placed in the 96-well
plates were as follows: buffer or LUVs suspension – 0.3 mM; fluo-
rescein – 40 nM; AAPH – 30 mM; phenolic compound – 1, 2
and 3 lM; acetonitrile – 0.15%. Prior to the addition of the radi-
cal initiator, the buffer (or the LUVs) and the phenol were incu-
bated at 378C, for 10 min, in the multiplate reader. The maxi-
mum of fluorescence emission (kex: 485/20 nm, kem: 528/20 nm)
was set to l 86104.
DPH-PA assay
EPC liposomes containing a radical sensitive fluorescent probe
(DPH-PA) (38 lL of a 60% (w/v) methanolic solution) were used.
The method of Arora et al. [44] was modified in order to be
applied to amultiplate reader.
Reagents were introduced in 96-well plates as follows: 160 lL
of the LUVs suspension, 70 lL of a solution of AAPH (64.27 mM
in Hepes/NaCl solution), 70 lL of solutions of the polyphenol
under study (6.42, 32.14, and 64.28 lM in Hepes/NaCl solution)
containing 6.5% of ethanol or 70 lL of Hepes/NaCl solution. The
final concentrations used were: 0.80 mM in LUVs, 15.00 mM in
AAPH, 1.50, 7.50, and 15.00 lM in polyphenol, 1.5% in ethanol.
Before the addition of the radical initiator, the LUVs and the pol-
yphenol were shaken at 378C for 10 min, in the multiplate
reader. The maximum of fluorescence emission (kex: 360/40 nm,
kem: 460/40 nm) was set to l 86104 (by tuning the sensitivity of
the fluorescence detector of the multiplate reader) and set to
100% of fluorescence emission (0% of oxidation).
For both fluorescein and DPH-PA assays AAPH is added and the
fluorescence decay over time was recorded at regular intervals
at 378C for a 3-hour period. Trolox was used as a reference anti-
oxidant.
The area under the curve of a control assay (without polyphe-
nol) was subtracted from the area obtained for each concentra-
tion of polyphenol tested. For each compound, the reduced area
was divided by the reduced area obtained for trolox, to yield
TEAC values. Each assay was performed in triplicate.
Determination of partition coefficients (Kp)
Partition coefficients were determined for the two phenolic
esters, at pH 7.4 and 258C, using egg phosphatidylcholine (EPC)
as the biomembrane model. The method of Kitamura et al. [46]
was adapted in order to use amultiplate reader.
Solutions in 96-well plates contained: liposomes (LUVs) in buf-
fer (Hepes: 0.005 M, I = 0.1 M (NaCl), pH 7.4) (from 0 to 500 lM),
phenolic compound tested (50 lM) and ethanol (1.66%). Themix-
tures were stirred for 1 min and left standing for 30 min in the
multiplate reader, at 258C, in order to allow membrane parti-
tion. UV/Vis spectra of the solutions were recorded between
250 nm and 400 nm, every 2 nm. Blank spectra (solutions with-
out phenolic compound) were measured and subtracted from
the sample spectra for each corresponding liposome concentra-
tion. Data were treated according to Kitamura et al. [46]. The par-
tition coefficient of the phenolic acid was previously determined
by derivative spectrophotometry, using micelles of 1-hexadecyl-
phosphoryl-choline (HDPC), at pH 2 and at 258C [47].
Biological assays
Preparation of solutions: all compounds studied were water
soluble in the concentration range used – from 2.5610 – 5 M to
1.0610– 4 M. Samples were prepared in phosphate buffered sal-
ine solution (PBS): 132.0610 – 3M NaCl, 4.0610 – 3 M KCl;
1.2610– 3M NaH2PO4; 1.4610 – 3 M MgCl2; 6.0610– 3 M glucose;
1.0610– 2 M HEPES (N-[2-hydroxyethyl]piperazine-N9-[4-butane-
sulphonic acid]). Fresh solutions were prepared monthly and
kept from light, in order to prevent oxidation. Trypan blue was
used as a 0.04% (w/v) solution in PBS. MTT (3-[4,5-dimethylthia-
zol-2-yl]-2,5-diphenyl-tetrazolium bromide) was prepared, in a
concentration of 0.5 mg/mL, in PBS solution containing
1.0610– 3M CaCl2.
Cell culture
Stock cultures of cells were maintained at 378C, under 5% CO2.
HeLa and L-132 (grown in monolayers) were kept in Dulbecco's
modified Eagle's high glucose (4500 mg/L) medium (DMEM-HG),
supplemented with 10% heat-inactivated fetal calf serum, gluta-
mine (1.168 g/L) and antibiotics (100 units of penicillin and
100 mg streptomycin). The cell lines were subcultured twice a
week. HeLa cells were harvested using a dissociation medium
composed of 136.9610 – 3 M NaCl, 2.7610 – 3 M KCl, 8.2610– 3M
Na2HPO4, 1.5610 – 3M KH2PO4, 4.0610 – 4 M EDTA (ethylene-dia-
minetetraacetic acid, disodium salt, dihydrate) (pH 7.4) and con-
taining 0.0004% (w/v) phenol red. L-132 cells were harvested
with a trypsin / EDTA solution (0.05% trypsin, 0.35 mM EDTA 4
Na, reconstituted in balanced salt solution without Ca2+or Mg2+).
Cytotoxicity and cell growth inhibition evaluation
Cytotoxicity and cell density evaluation after drug exposure –
for drug concentrations between 2.5610 – 5 M and 1.0610 – 4 M
– was assessed with use of standard assays. Cells were plated at
56105 cells/mL. In a time of 24 h hours after seeding, drug solu-
tions were added to the medium and the cultures were incu-
bated at 378C. Cells were harvested and analyzed (both in con-
trols and in drug-treated cultures) every 24 hours, for a total
period of three days. Reversibility of the drug effect was tested
by removing the drug and adding fresh culture medium in the
last day of incubation with the drug, and assessing the cell via-
bility following four more days of incubation. Cell density and
viability were determined by Trypan blue exclusion on single-
cell suspensions obtained from the monolayer cultures. Cell via-
bility was further assessed by the Alamar blue colorimetric test
[67, 17, 18]. All experiments were performed in triplicate.
All the results presented were obtained by two independent
methods: cell density measurement – Trypan blue exclusion
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method – and cell viability assessment – Alamar blue colorimet-
ric assay [17, 18].
Data analysis
All experiments were performed in triplicate. The results are
expressed as mean values l SD, (the corresponding error bars
being displayed in the graphical plots). Statistical analysis was
performed using ANOVA, followed by post hoc test of Fisher's
Protected Least Significant Difference. Statistical comparison
between the data was based on the Pearson correlation coeffi-
cient, values less than 0.05 being considered as significant.
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